Topic acne

News acne

• AstraZeneca and Galderma Enter into R&D Collaboration to Develop New Treatments for Dermatological Diseases

  AstraZeneca and Galderma Pharma S.A. announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of peop more

• Photocure establishes US subsidiary to build speciality dermatology business

  Photocure announced the establishment of its US subsidiary, Photocure Inc, and the appointment of Terry Conrad as President to build its specialty dermatology business in the US. Terry Conrad has over 23 years experience in the pharmaceutical industry and has held senior marketing, sales and busine more

• Bayer: YAZ approved in Japan for the treatment of dysmenorrhea

  Bayer Schering Pharma AG, Germany, and Bayer Yakuhin, Ltd., Japan, announced that the Japanese regulatory authorities have granted approval for YAZ® (3 mg drospirenone/20 mcg ethinyl estradiol) for the treatment of dysmenorrhea. YAZ is available in the US, Europe, Latin America and the region Asia more

Publications acne

• Effect of Lactobacillus reuteri on the proliferation of Propionibacterium acnes and Staphylococcus epidermidis

  While it is generally accepted that Propionibacterium acnes is involved in the development of acne, other bacteria including Staphylococcus epidermidis have also been isolated from the acne lesion. The interaction between Lactobacillus reuteri, a probiotic bacterium, and acnegenic bacteria is unclea more

• Comparative Photodynamic Evaluation of New Phenothiazinium Derivatives against Propionibacterium acnes†

  Abstract The screening of recently patented derivatives of the standard phenothiazinium agents methylene blue and toluidine blue was carried out against Propionibacterium acnes, the main bacterium associated with acne vulgaris. Comparative tests were made using the topical agent benzoyl peroxide more

• [Brevia] γ-Secretase Gene Mutations in Familial Acne Inversa

  Mutations causing a rare skin disease reveal a signaling pathway that is a drug target for Alzheimer’s disease. more

Market studies acne

• Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline

  GBI Research, the leading business intelligence provider, has released its latest research, “Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline”. It provides in-depth analysis of the unmet needs, drivers and more

• Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

  GBI Research, the leading business intelligence provider, has released its latest research ‘Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials’ which provides an insight into different endpoints that are used in more

• Acne Vulgaris – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides information on the therapeutic development for Acne Vulgaris, complete with latest updates, and special features on late-stage and more

Websites acne